Roche (OTCMKTS:RHHBY) Cut to Sell at Deutsche Bank Aktiengesellschaft

Deutsche Bank Aktiengesellschaft lowered shares of Roche (OTCMKTS:RHHBY) from a hold rating to a sell rating in a research report released on Friday morning, MarketBeat Ratings reports.

Several other research firms have also recently weighed in on RHHBY. Bank of America raised Roche from a neutral rating to a buy rating in a report on Friday. The Goldman Sachs Group assumed coverage on Roche in a research note on Thursday, May 30th. They set a sell rating on the stock. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of Hold.

Roche Stock Performance

Shares of OTCMKTS RHHBY opened at $39.11 on Friday. The company has a quick ratio of 1.04, a current ratio of 1.35 and a debt-to-equity ratio of 0.75. The business’s fifty day moving average price is $39.59 and its 200-day moving average price is $34.82. Roche has a one year low of $29.20 and a one year high of $42.43.

Institutional Investors Weigh In On Roche

Several institutional investors and hedge funds have recently made changes to their positions in RHHBY. Bard Financial Services Inc. boosted its stake in shares of Roche by 2.0% during the 1st quarter. Bard Financial Services Inc. now owns 20,200 shares of the company’s stock worth $645,000 after acquiring an additional 400 shares during the last quarter. SVB Wealth LLC boosted its stake in shares of Roche by 2.6% during the 1st quarter. SVB Wealth LLC now owns 16,646 shares of the company’s stock worth $531,000 after acquiring an additional 426 shares during the last quarter. Confluence Investment Management LLC boosted its stake in shares of Roche by 3.7% during the 2nd quarter. Confluence Investment Management LLC now owns 12,922 shares of the company’s stock worth $448,000 after acquiring an additional 459 shares during the last quarter. Norman Fields Gottscho Capital Management LLC boosted its stake in shares of Roche by 2.3% during the 2nd quarter. Norman Fields Gottscho Capital Management LLC now owns 24,650 shares of the company’s stock worth $858,000 after acquiring an additional 550 shares during the last quarter. Finally, Archer Investment Corp boosted its stake in shares of Roche by 10.6% during the 2nd quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock worth $236,000 after acquiring an additional 652 shares during the last quarter.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.